HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

procyanidol oligomer

Also Known As:

Endotelon

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Benakis, A: 1 article (01/2008)
2.	Ritschard, J: 1 article (01/2008)
3.	Schopfer, C: 1 article (01/2008)
4.	Dolyk, S S: 1 article (06/2004)
5.	Gusak, V K: 1 article (10/2000)
6.	Il'iushchenko, S V: 1 article (10/2000)
7.	Iurchuk, A Iu: 1 article (10/2000)
8.	Rodin, Iu V: 1 article (10/2000)
9.	Shtutin, A A: 1 article (10/2000)

Related Diseases

1.	Venous Insufficiency 09/01/1991 - "Endotelon (Procyanidolic Oligomers, Sanofi-Labaz Laboratories) are recognized "angioprotectors" for human venous insufficiency. " 01/01/2008 - "ENDOTELON consists of a complex of procyanidolic oligomers extracted from the seeds of a variety of vine cultivated in the Bordeaux wine-growing region, and is prescribed for the treatment of chronic venous insufficiency and retinal lesions. "
2.	Edema (Dropsy) 09/01/1991 - "These results suggest that Endotelon may reduce or prevent postoperative acute edema." 01/01/1984 - "[Effect of Endotelon in postoperative edema. " 09/01/1991 - "When administered just before lymphedema became established (i.e., curatively), Endotelon and Coumarin (another "angioprotector") failed to affect hindlimb edema. "
3.	Neoplasms (Cancer) 06/01/2004 - "[Practical experience of endotelon application in patients with cervix uteri cancer after extended panhysterectomy]." 06/01/2004 - "Application of endotelon in early period after extended panhysterectomy in patients with cervix uteri cancer of I-II stages promotes reduction of the occurrence frequency of retroperitoneal lymphatic cyst and lymphostasis in parametrium and lower extremities."
4.	Lymphocele 06/01/2004 - "Application of endotelon in early period after extended panhysterectomy in patients with cervix uteri cancer of I-II stages promotes reduction of the occurrence frequency of retroperitoneal lymphatic cyst and lymphostasis in parametrium and lower extremities."
5.	Lymphedema (Milroy Disease) 09/01/1991 - "In this experimental counterpart of acute lymphedema, Endotelon (400mg/kg/day p.o.) administered "prophylactically" (i.e., before, during, and 7 days after development of lymphedema) decreased rat hindlimb lymphedema by approximately 4.7%. " 09/01/1991 - "Using an operative experimental model of lymphedema, we sought pharmacological evidence for potential lymphagogue activity of Endotelon. " 09/01/1991 - "Effect of Endotelon (procyanidolic oligomers) on experimental acute lymphedema of the rat hindlimb." 09/01/1991 - "When administered just before lymphedema became established (i.e., curatively), Endotelon and Coumarin (another "angioprotector") failed to affect hindlimb edema. "

Related Drugs and Biologics

1.	Retinaldehyde (Retinal)
2.	coumarin